EMA greenlights another Covid jab as booster — Analysis
The European Medicines Agency (EMA) on Wednesday approved the Johnson & Johnson (J&J) Covid shot as a booster jab for people aged 18 and over, to be administered at least two months after they received their previous dose.
The European regulator approved the J&J booster dose for usage after data showed that it increases antibodies that protect against the Covid pandemic, as nations rush to find ways to contain the spread of Omicron.
In its assessment, the EMA stated that public health officials across the EU are now cleared to administer the J&J jab as a booster after one dose of the company’s Jansen Covid jab or two doses of the Pfizer or Moderna mRNA vaccines.
Six months ago, the EMA approved the Moderna and Pfizer booster jabs. The agency is currently weighing authorizing AstraZeneca’s booster dose.
In an effort to increase protection for citizens from the Omicron pandemic, countries around the globe have intensified their vaccination programs in the last few weeks. Omicron poses a threat to human health, according to the World Health Organization. “very high”Its high transmissibility poses a risk.